KorrekturOpen access · CC BY 4.0
Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer”
Advanced Science · 2026-06 · 13 (33)
DOI: 10.1002/advs.75571 ↗At a glance
Korrektur in Advanced Science, published online on 2026-05-07. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Intet abstract tilgængeligt.
Cite
APA
(2026). Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer”. Advanced Science, 13(33). https://doi.org/10.1002/advs.75571
Vancouver
Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer”. Advanced Science. 2026;13(33). doi:10.1002/advs.75571
BibTeX
@article{euvimed2026,
title = {Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer”},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {33},
doi = {10.1002/advs.75571}
}
EUVIMED